Jun 30, 2026 · 7 min
European stocks surge as Abivax and Maersk upgrade market outlooks
Abivax Up, Maersk Jumps, Sainsbury's Rise
Strong corporate earnings and clinical breakthroughs are boosting investor confidence in European biotech, logistics, and retail sectors.
- 1Abivax shares surged up to 27 percent after clinical trial updates eased safety fears for its bowel disease drug.
- 2Shipping giant Maersk raised its profit outlook due to booming global container demand, particularly in Asian markets.
- 3Sainsbury's reported resilient first-quarter sales that met market expectations and outperformed its main competitor Tesco.
The brief
European markets are showing strong momentum as biotech breakthroughs, global shipping demands, and resilient grocery retail sectors drive unexpected stock surges across the continent.
French biotech firm Abivax saw its shares jump up to 27 percent after positive clinical trial updates for its inflammatory bowel disease drug alleviated lingering cancer safety concerns.
Global shipping giant Maersk upgraded its full-year profit outlook, driven by robust container demand in Asia that signals healthier global trade volumes than previously anticipated.
British supermarket chain Sainsbury's outpaced its rival Tesco with resilient first-quarter sales that met expectations, proving grocery retail can hold firm despite economic headwinds.
What was said on this episode
7 statements · 5 positive · 1 negative · 1 neutral
Positive trial results could revive takeover interest in Abivax
“we could see some of that takeover interest rise up again”
Listen at 2:08
The global container market is expected to remain healthy through 2026
“a global container market that looks to stay very healthy throughout the rest of this year, the rest of 2026”
Listen at 2:30
Freight volumes generally increase during summer
“freight volumes also do go up generally over the summer”
Listen at 3:00
Demand, market health, disruption, and seasonal volumes improved Maersk’s outlook
“all of those reasons, they've all kind of aligned to brighten that outlook for Maersk”
Listen at 3:11
Sainsbury’s expects profit to remain roughly unchanged from last year
“it said that profit would be about the same as last year”
Listen at 3:48
Sainsbury’s aims to retain market share against discount retailers
“Sainsbury's because they want to retain market share against those discount retailers like Aldi and Lidl”
Listen at 4:19
Iran war effects create uncertainty around Sainsbury’s outlook
“that's going to be something that creates a little bit of uncertainty around the outlook going forward for Sainsbury's”
Listen at 4:50
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Inflammatory bowel diseaseBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.